Results 31 to 40 of about 3,155,278 (304)
Insulin Therapy and Cancer [PDF]
Diabetes Care, 2013 That diabetes is associated with an increased lifetime risk of developing malignancy is now well established (1,2). For some specific malignancies, explanation of that increased risk is possible, though usually unproven. For example, the marked increase in pancreatic cancer incidence in type 2 diabetes may or may not be due to misattribution of type of
openaire +3 more sources
Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol : a pilot study [PDF]
, 2013 Background: Incidental adrenal masses are commonly detected during imaging for other pathologies. 10% of the elderly population has an ‘adrenal incidentaloma’, up to 20% of these show low-grade autonomous cortisol secretion and 60% of patients with ...
Rita Chadarevian +19 more
core +1 more source
Journal of Human Reproductive Sciences, 2010 Aims : To evaluate if 2-h post glucose insulin level is an effective tool to monitor insulin resistance in response to metformin therapy, in infertile women with polycystic ovarian syndrome (PCOS).
Pikee Saxena +2 more
doaj +1 more source
Gestational diabetes mellitus: A Narrative Review
Medical Journal of Babylon, 2021 Diabetes mellitus (DM) is a chronic disease that needs medical support and continuing patient education to avoid acute complications and decrease the long-term complications. The prevalence of diabetes is high in many areas, especially Asian.
Alaa Ibrahim Ali, Wassan Nori
doaj +1 more source
Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
Сахарный диабет, 2012 Article reviews basic steps and regimens of insulin analogue therapy intensification in patients with type 2 diabetes mellitus (T2DM). Intensification of insulin therapy is commonly implemented by supplementation of basal insulin with prandial before ...
Alexander Sergeevich Ametov +1 more
doaj +1 more source
Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
Open Medicine, 2022 We evaluated the clinical impact, in daily clinical practice, of sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) therapies in patients with type 2 diabetes.
Piazzolla Giuseppina +9 more
doaj +1 more source
Food & Nutrition Research, 2021 Aims: To identify factors predicting a need for insulin therapy in gestational diabetes mellitus (GDM) by comparing plasma glucose (PG) levels in a 75-g oral glucose tolerance test (75-g OGTT) with those in a 500-kcal meal tolerance test (MTT) containing
Mai Hijikata +3 more
doaj +1 more source
The Pan African Medical Journal, 2019 INTRODUCTION: Adherence to insulin therapy is a critical factor for adequate control of diabetes mellitus. Despite the multiple well-known benefits of adherence to insulin therapy, poor adherence remains to be a common cause of diabetes mellitus-related ...
Teklewoini Mariye +8 more
doaj +1 more source
Insulin Therapy and Hypoglycemia [PDF]
Endocrinology and Metabolism Clinics of North America, 2002 Hypoglycemia is the most important and common side effect of insulin therapy. It is also the rate limiting factor in safely achieving excellent glycemic control. A three-fold increased risk of severe hypoglycemia occurs in both type 1 and type 2 diabetes with tight glucose control.
openaire +2 more sources
Diabetic macroangiopathy and self-monitoring of glucose
Медицинский совет, 2014 Diabetic macroangiopathy is a general term for atherosclerotic vascular diseases of large- and medium-caliber arteries in diabetes mellitus (DM). Macrovascular complications of diabetes leading to cardiovascular diseases (CVD) are the major cause of ...
OS Fedorova
doaj +1 more source